Font size
- 1 2 3 + Font size

click to adjust

Page tools
. Advanced search

A Targeted Approach to HealthCare

Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.

For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.

Bayer News Releases

18 December 2014
Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® (radium Ra 223 dichloride) Injection

17 December 2014
Bayer Submits Biologics License Application for BAY 81-8973 for the Treatment of Hemophilia A in Adults and Children

24 November 2014
FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation

18 November 2014
Bayer Launches Breathless Moments Contest For First Annual CTEPH Awareness Day

3 November 2014
Bayer HealthCare & KARL STORZ Enter Collaboration Agreement to Provide Gynecologists Hysteroscopy Solutions Supporting the Procedure for Essure® Permanent Birth Control

24 September 2014
ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise

17 September 2014
Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C

16 September 2014
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer

08 September 2014
Bayer HealthCare Launches Make Your Mark to Inspire Women and Celebrate Their Achievements


Press Release Archive


Further Information

Clinical Trials

Information about clinical studies is available at

Copyright © Bayer Healthcare Pharmaceuticals